Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020

SKU ID : TNV- 10289427

Publishing Date : 03-Nov-2016

No. of pages : 98


  • About Autoimmune and Inflammatory Immunomodulators

    Immunomodulators are the drugs that help to regulate the immune system. These drugs either stimulate the weak immune systems or moderate the overactive immune systems. Though many drugs are available in the market, there still exists a huge unmet need in the autoimmune and inflammatory immunomodulators market as there are no medicines that provide complete cure to some diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn’s disease.

    Technavio’s analysts forecast the global autoimmune and inflammatory immunomodulators market to grow at a CAGR of 7.01% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global autoimmune and inflammatory immunomodulators market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • AbbVie
    • Johnson & Johnson
    • Amgen
    • F. Hoffmann-La Roche
    • Pfizer

    Other prominent vendors
    • AstraZeneca
    • Avaxia Biologics
    • Biogen Idec
    • Bristol-Myers Squibb
    • Boehringer Ingelheim
    • Eli Lilly
    • Enlivex Therapeutics
    • Gilead Sciences
    • Immune Pharmaceuticals
    • Merck
    • Mitsubishi Tanabe Pharma
    • Neovacs
    • Prometheus Laboratories
    • Sandoz
    • Sanofi
    • Swedish Orphan Biovitrum
    • Takeda Pharmaceuticals
    • UCB

    Market driver
    • Development of novel therapies using innovative technologies.
    • For a full, detailed list, view our report

    Market challenge
    • Discontinuation of drugs under development leading to substantial loss in revenue.
    • For a full, detailed list, view our report

    Market trend
    • Advent of biosimilars expected to improve the treatment rates.
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

    Frequently Asked Questions

    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports